{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-365287","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2026-08-25T20:57:06+00:00","discovered_at":"2026-08-25T20:59:07.390936+00:00","generated_at":"2026-08-25T20:59:14.046169+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"REGENXBIO appoints Greg Ciongoli to board; two directors retire effective Aug 25, 2026","bullets":["Ciongoli elected as independent Class II director, term expires at 2029 annual meeting.","Granted initial equity award with $550,000 fair value (75% option, 25% RSUs), exercise price $8.91, 3-year vesting.","Annual board retainer of $45,000 plus $10,000 audit and $5,000 nominating committee retainers.","Jean Bennett and Jerry Karabelas resigned as directors; will serve as advisors until February 2027.","Board size reduced to nine directors effective immediately."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-365287","json":"https://secwatch.observer/filing/0001193125-26-365287.json","markdown":"https://secwatch.observer/filing/0001193125-26-365287.md","text":"https://secwatch.observer/filing/0001193125-26-365287.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526365287/0001193125-26-365287-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000119312526365287/rgnx-20260825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-25T20:59:14.046169+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}